205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.16%
Net income growth under 50% of MRVL's 116.25%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.09%
Less D&A growth vs. MRVL's 11.10%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
600.00%
Deferred tax of 600.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
-22.53%
Both reduce yoy usage, with MRVL at -135.21%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
16.46%
Some inventory rise while MRVL is negative at -92.75%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-100.00%
Negative yoy AP while MRVL is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-2988.89%
Both reduce yoy usage, with MRVL at -20.30%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
No Data
No Data available this quarter, please select a different quarter.
28.75%
Some CFO growth while MRVL is negative at -3.11%. John Neff would note a short-term liquidity lead over the competitor.
11.22%
CapEx growth well above MRVL's 0.66%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Acquisition growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-14.43%
Both yoy lines negative, with MRVL at -1112.13%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
13.68%
Below 50% of MRVL's 909.23%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-100.00%
Both yoy lines negative, with MRVL at -448.22%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
7.96%
We have mild expansions while MRVL is negative at -103.95%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
64.29%
Lower share issuance yoy vs. MRVL's 812.84%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
34.30%
Buyback growth of 34.30% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.